In vitro assays to predict the severity of hemolytic disease of the newborn.
Hadley
A G
AG
International Blood Group Reference Laboratory, Bristol, United Kingdom.
D000649:Amniocentesis; D000920:Antibody-Dependent Cell Cytotoxicity; D004899:Erythroblastosis, Fetal / Q000097:blood / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control; D005260:Female; D005312:Fetal Blood / Q000166:cytology / Q000276:immunology; D005434:Flow Cytometry; D006031:Glycosylation; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007074:Immunoglobulin G / Q000737:chemistry / Q000145:classification / Q000276:immunology; D007231:Infant, Newborn; D007518:Isoantibodies / Q000737:chemistry / Q000145:classification / Q000276:immunology; D008163:Luminescent Measurements; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000276:immunology; D011296:Prenatal Diagnosis; D017452:Receptors, IgG / Q000235:genetics / Q000276:immunology; D016897:Respiratory Burst; D012203:Rh Isoimmunization / Q000175:diagnosis*; D012397:Rosette Formation; D012720:Severity of Illness Index
D007074:Immunoglobulin G; D007518:Isoantibodies; D017452:Receptors, IgG